Key points are not available for this paper at this time.
Salmonella enterica subspecies enterica serovar Minnesota ( S. Minnesota) is an emerging serovar in Brazilian poultry production. This study aimed to characterize the antimicrobial resistance profile of 20 S. Minnesota strains isolated from broiler chicken litter in Paraná, southern Brazil, between 2021 and 2023, and to confirm these findings with whole-genome sequencing. Antimicrobial susceptibility testing showed all isolates were multidrug resistant. High resistance rates were observed against ciprofloxacin (100%), ceftazidime (95%), and gentamicin (70%). Genomic analysis confirmed the resistance profiles, revealing key resistance determinants: the beta-lactamase gene bla CMY-2 was present in all isolates; parC p.T57S mutation was present in all isolates, along with plasmid-borne qnrB genes in some, correlating with ciprofloxacin resistance; and aminoglycoside resistance genes such as aac(6′)-Iy , aph(3)-Ia , and aadA were detected. Additionally, all isolates belonged to sequence type ST548 and carried tet(A) , sul2 , and acrB resistance genes. A major finding was a discrepancy in in-silico serotyping. While SISTR identified all strains as S. Minnesota, SeqSero identified one as S. Minnesota and 19 as S. Rochdale, a difference that highlights the limitations of serological and in-silico methods for closely related serovars. These results emphasize the spread of MDR S. Minnesota in poultry and the necessity of genomic surveillance for accurate resistance monitoring and public health protection. • Antimicrobial susceptibility testing found multidrug resistant Salmonella Minnesota in Brazilian poultry. • All isolates were phenotypically resistant to ceftazidime, ciprofloxacin and aminoglycosides. • Strains carrying plasmid-borne qnrB genes were observed. • Additional resistance genes, including tet(A) , sul2 , and acrB, were also identified in all isolates. • A key finding was the discrepancy between in silico serotyping tools.
Mesa et al. (Tue,) studied this question.